In this episode Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches Top 5 picks, discussing the link between opioid prescribing and suicide, the role of GLP-1 receptor agonists in the treatment of SUDs, the positive data on using amitriptyline, pregabalin and duloxetine in diabetic peripheral neuropathic pain, and more!
Childhood trauma increases risk of chronic pain in adulthood, research to-date highlights Published in Science Daily, December 2023.
Opioid Prescribing and Suicide Risk in the United States Published in the American Journal of Psychiatry, June 2023
The impact of fentanyl on state- and county-level psychostimulant and cocaine overdose death rates by race in Ohio from 2010 to 2020: a time series and spatiotemporal analysis Published in the Harm Reduction Journal, January 2024
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders Published in the British Journal of Pharmacology, February 2022
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. Published in the Lancet, August 2022
